[Form 4] Standex International Corporation Insider Trading Activity

Rhea-AI Filing Summary

Standex International Corp. (SXI) director Thomas J. Hansen reported a sale of common stock on 08/18/2025. The filing shows 2,992 shares sold in one or more transactions at a weighted average price of $202.6049, with individual sale prices ranging from $201.045 to $203.540. After the reported sale, the filing lists 8,439.254 shares beneficially owned by the reporting person in a direct ownership form. The Form 4 is executed on behalf of the reporting person by Alan J. Glass and signed on 08/20/2025. The filer is identified as a director of the issuer, Standex International Corporation (SXI).

Positive

• Transparent pricing disclosure: the filing provides a weighted average sale price and the full range of execution prices.
• Compliance detail: Form 4 includes post-transaction beneficial ownership and direct ownership form, satisfying standard disclosure fields.

Negative

• No stated 10b5-1 plan or written plan checkbox checked, so the filing does not indicate pre-established trading authorization.
• Limited context: the filing does not explain the reason for the sale or indicate whether multiple transactions were part of a larger program.

Insights

Securities Analyst

TL;DR: Director sale of 2,992 shares at ~$202.60; disclosed on Form 4 with direct ownership remaining.

The transaction is a straightforward Section 16 disclosure showing a director-initiated sale of common stock executed on 08/18/2025. The filing provides a weighted average sale price and the range of execution prices, and it reports the post-transaction direct beneficial ownership as 8,439.254 shares. The form is signed on 08/20/2025 by Alan J. Glass on behalf of the reporting person. From a compliance perspective, the filing meets Rule 16 reporting format and includes the required explanation of price range for multiple trades.

Corporate Governance Expert

TL;DR: Routine insider sale disclosed; no additional context on plan or reason provided.

This Form 4 documents a director's sale without attaching a Rule 10b5-1 plan checkbox or explanatory motive. The disclosure includes the weighted average sale price and explicit price range, which improves transparency. The post-transaction direct ownership figure is stated. The filing does not include any indication of an amendment to a prior Form 4 or that the reporting person is no longer subject to Section 16 obligations.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HANSEN THOMAS J

(Last) (First) (Middle)

STANDEX INTERNATIONAL CORPORATION

23 KEEWAYDIN DRIVE, STE. 300

(Street)

SALEM NH 03079

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
STANDEX INTERNATIONAL CORP/DE/ [ SXI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/18/2025		S		2,992	D	$202.6049(1)	8,439.254	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $201.045 to $203.540, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price.

	/s/ Alan J. Glass	08/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Standex (SXI) Form 4 filed by Thomas J. Hansen disclose?

The Form 4 discloses a sale of 2,992 common shares executed on 08/18/2025 at a weighted average price of $202.6049 (range $201.045–$203.540), with 8,439.254 shares reported beneficially owned after the sale.

Was the sale by Thomas J. Hansen made under a Rule 10b5-1 trading plan?

The filing does not check or state that the transaction was made pursuant to a Rule 10b5-1 written plan.

Who signed the Form 4 for the reporting person and when?

The Form 4 bears the signature of Alan J. Glass dated 08/20/2025 on behalf of the reporting person.

What ownership form is reported after the transaction?

The filing reports the ownership form as Direct (D) with 8,439.254 shares beneficially owned following the reported sale.

Does the Form 4 indicate the sale was part of multiple transactions?

Yes; the explanation states the shares were sold in multiple transactions at prices ranging from $201.045 to $203.540, and the filer offers to provide detailed per-trade quantities on request.